AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RANITIDINE HYDROCHLORIDE
18 registrations across 3 African markets— 6 active
Markets with RANITIDINE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| NELSTAC 150 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS (PTY) LTD | active | Dec 2027 |
| RANITIDINE HYDROCHLORIDE SOLUTION; INJECTION | 🇿🇼Zimbabwe | PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L | active | Dec 2027 |
| ULCERAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | CAPS PVT LTD | active | Dec 2027 |
| ENTAC SOLUTION | 🇿🇼Zimbabwe | WMT PHARMACEUTICALS PVT LTD | active | Dec 2027 |
| ZANTAC-RANITIDINE 300 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| GLAX0-RANITIDINE 300 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| GLAX0-RANITIDINE 150 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| RANTAC INJECTION | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| RANTEEN 150 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| RANTEEN 300 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| RANTAC 150 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ACILOC-150 150MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2018 |
| HISTAC 28MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2011 |
| RANITIN 300MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2007 |
| ZORAN 150MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jul 2003 |
| RINTID 150MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2003 |
| EBUNAZIINJECTION | 🇿🇦South Africa | Bliss Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| EBUNAZI 300 TABLETS | 🇿🇦South Africa | Bliss Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
RANITIDINE HYDROCHLORIDE in Africa — Regulatory Overview
RANITIDINE HYDROCHLORIDE is registered across 3 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Malawi, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 6 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.